157 related articles for article (PubMed ID: 9869861)
1. Evaluation of immunoisolated insulin-secreting beta TC6-F7 cells as a bioartificial pancreas.
Mamujee SN; Zhou D; Wheeler MB; Vacek I; Sun AM
Ann Transplant; 1997; 2(3):27-32. PubMed ID: 9869861
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of insulin-producing beta TC6-F7 cells in microcapsules.
Zhou D; Sun AM; Li X; Mamujee SN; Vacek I; Georgiou J; Wheeler MB
Am J Physiol; 1998 May; 274(5):C1356-62. PubMed ID: 9612223
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of transplanted microencapsulated fetal pancreatic cells.
Foster JL; Williams G; Williams LJ; Tuch BE
Transplantation; 2007 Jun; 83(11):1440-8. PubMed ID: 17565317
[TBL] [Abstract][Full Text] [Related]
4. Glucose-responsitivity and expression of an ATP-stimulatable, Ca(2+)-independent phospholipase A2 enzyme in clonal insulinoma cell lines.
Ramanadham S; Wolf MJ; Li B; Bohrer A; Turk J
Biochim Biophys Acta; 1997 Jan; 1344(2):153-64. PubMed ID: 9030192
[TBL] [Abstract][Full Text] [Related]
5. Intrasplenic transplantation of encapsulated genetically engineered mouse insulinoma cells reverses streptozotocin-induced diabetes in rats.
Aoki T; Hui H; Umehara Y; LiCalzi S; Demetriou AA; Rozga J; Perfettit R
Cell Transplant; 2005; 14(6):411-21. PubMed ID: 16180660
[TBL] [Abstract][Full Text] [Related]
6. Cyotomedical therapy for insulinopenic diabetes using microencapsulated pancreatic beta cell lines.
Suzuki R; Okada N; Miyamoto H; Yoshioka T; Sakamoto K; Oka H; Tsutsumi Y; Nakagawa S; Miyazaki J; Mayumi T
Life Sci; 2002 Aug; 71(15):1717-29. PubMed ID: 12151050
[TBL] [Abstract][Full Text] [Related]
7. Incretin hormones regulate glucose-dependent insulin secretion in RIN 1046-38 cells: mechanisms of action.
Montrose-Rafizadeh C; Egan JM; Roth J
Endocrinology; 1994 Aug; 135(2):589-94. PubMed ID: 8033807
[TBL] [Abstract][Full Text] [Related]
8. C-peptide responses after meal challenge in mice transplanted with microencapsulated rat islets.
Tatarkiewicz K; Garcia M; Omer A; Van Schilfgaarde R; Weir GC; De Vos P
Diabetologia; 2001 May; 44(5):646-53. PubMed ID: 11380084
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats.
Perfetti R; Zhou J; Doyle ME; Egan JM
Endocrinology; 2000 Dec; 141(12):4600-5. PubMed ID: 11108273
[TBL] [Abstract][Full Text] [Related]
10. Glucose-insulin kinetics of the extravascular bioartificial pancreas. A study using microencapsulated rat islets.
Soon-Shiong P; Heintz R; Yao Z; Yao Q; Sanford P; Lanza RP; Meredith N
ASAIO J; 1992; 38(4):851-4. PubMed ID: 1450485
[TBL] [Abstract][Full Text] [Related]
11. Bioartificial pancreas: alternative supply of insulin-secreting cells.
Zhou D; Kintsourashvili E; Mamujee S; Vacek I; Sun AM
Ann N Y Acad Sci; 1999 Jun; 875():208-18. PubMed ID: 10415569
[TBL] [Abstract][Full Text] [Related]
12. Effects of glucagon-like peptide-1 (GLP-1) in RINm5F insulinoma cells. Stimulation of insulin secretion, insulin content, and insulin receptor binding.
Jehle PM; Jehle D; Fussgänger RD; Adler G
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():31-6. PubMed ID: 8839251
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats.
Farilla L; Hui H; Bertolotto C; Kang E; Bulotta A; Di Mario U; Perfetti R
Endocrinology; 2002 Nov; 143(11):4397-408. PubMed ID: 12399437
[TBL] [Abstract][Full Text] [Related]
14. Reduction of beta cell mass: partial insulin secretory compensation from the residual beta cell population in the nicotinamide-streptozotocin Göttingen minipig after oral glucose in vivo and in the perfused pancreas.
Larsen MO; Rolin B; Gotfredsen CF; Carr RD; Holst JJ
Diabetologia; 2004 Nov; 47(11):1873-8. PubMed ID: 15565374
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
16. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
Parkes DG; Pittner R; Jodka C; Smith P; Young A
Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
[TBL] [Abstract][Full Text] [Related]
17. Anti-diabetic effects of Centratherum anthelminticum seeds methanolic fraction on pancreatic cells, β-TC6 and its alleviating role in type 2 diabetic rats.
Arya A; Looi CY; Cheah SC; Mustafa MR; Mohd MA
J Ethnopharmacol; 2012 Oct; 144(1):22-32. PubMed ID: 22954496
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line.
Waeber G; Thompson N; Waeber B; Brunner HR; Nicod P; Grouzmann E
Endocrinology; 1993 Sep; 133(3):1061-7. PubMed ID: 8396008
[TBL] [Abstract][Full Text] [Related]
19. Regulation of glycosylphosphatidylinositol-specific phospholipase D secretion from beta TC3 cells.
Deeg MA; Verchere CB
Endocrinology; 1997 Feb; 138(2):819-26. PubMed ID: 9003020
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells.
Wang Y; Egan JM; Raygada M; Nadiv O; Roth J; Montrose-Rafizadeh C
Endocrinology; 1995 Nov; 136(11):4910-7. PubMed ID: 7588224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
